![The sample size of the @_SOLTI @GroupeUnicancer RIBOLARIS phase II trial will be increased to 1,100 patients! – Aleix Prat](https://oncodaily.com/pub/uploads/2023/07/Prat-A-2022.jpg)
Photo taken from: Breast Cancer Research Foundation / Webpage
Jul 7, 2023, 10:04
The sample size of the @_SOLTI @GroupeUnicancer RIBOLARIS phase II trial will be increased to 1,100 patients! – Aleix Prat
Very happy to announce that the sample size of the @_SOLTI @GroupeUnicancer RIBOLARIS phase II trial will be increased to 1,100 patients!
Ribolaris trial design: https://bit.ly/3JQ3iBO
https://classic.clinicaltrials.gov/ct2/show/NCT05296746
Very happy to lead this project together with Prof. Paul Cottu, Prof. @GavilKino and Prof. Thibault de La Motte Rouge